Versican/PG-M is essential for ventricular septal formation subsequent to cardiac atrioventricular cushion development

Glycobiology

Volumn 22, Issue 9, 2012, Pages 1268-1277

  Hatano, Sonoko ^a   Kimata, Koji ^a   Hiraiwa, Noriko ^b   Kusakabe, Moriaki ^c   Isogai, Zenzo ^d   Adachi, Eijiro ^e   Shinomura, Tamayuki ^f   Watanabe, Hideto ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b RIKEN   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^e KITASATO UNIVERSITY   (Japan)

^f TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

atrioventricular cushion; endocardial mesenchymal transformation (EMT); hyarulonan; ventricular septa; versican

Indexed keywords

COLLAGEN GEL; HYALURONIC ACID; KI 67 ANTIGEN; VERSICAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATRIOVENTRICULAR CANAL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENDOCARDIAL CUSHION; ENDOCARDIUM; EX VIVO STUDY; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; FEMALE; HEART DEVELOPMENT; HEART VENTRICLE SEPTUM; HEART VENTRICLE SEPTUM DEFECT; MALE; MESENCHYME CELL; MOUSE; NEWBORN; NEWBORN PERIOD; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; CELL PROLIFERATION; CHONDROITIN SULFATE PROTEOGLYCANS; EMBRYO, MAMMALIAN; ENDOCARDIAL CUSHIONS; EXTRACELLULAR MATRIX; FEMALE; GENE DELETION; HEART SEPTAL DEFECTS, VENTRICULAR; HEART VENTRICLES; HYALURONIC ACID; MICE; MICE, KNOCKOUT; VERSICANS;

MUS;

EID: 84864462047     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cws095     Document Type: Article

References (39)

1. Armstrong EJ, Bischoff J. 2004. Heart valve development: Endothelial cell signaling and differentiation. Circ Res. 95:459-470.
2. Aspberg A, Adam S, Kostka G, Timpl R, Heinegard D. 1999. Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. J Biol Chem. 274:20444-20449.
3. Aspberg A, Miura R, Bourdoulous S, Shimonaka M, Heinegard D, Schachner M, Ruoslahti E, Yamaguchi Y. 1997. The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety. Proc Natl Acad Sci USA. 94:10116-10121.
4. Bouvagnet P, Sauer U, Debrus S, Genz T, Alonso S, Berger G, De Meeus A, Buhlmeier K, Demaille J. 1994. Deciphering the molecular genetics of congenital heart disease. Herz. 19:119-125.
5. Camenisch TD, Schroeder JA, Bradley J, Klewer SE, McDonald JA. 2002. Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors. Nat Med. 8:850-855.
6. Camenisch TD, Spicer AP, Brehm-Gibson T, Biesterfeldt J, Augustine ML, Calabro A, Jr, Kubalak S, Klewer SE, McDonald JA. 2000. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest. 106:349-360.
7. Choocheep K, Hatano S, Takagi H, Watanabe H, Kimata K, Kongtawelert P, Watanabe H. 2010. Versican facilitates chondrocyte differentiation and regulates joint morphogenesis. J Biol Chem. 285:21114-21125.
8. Eisenberg LM, Markwald RR. 1995. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ Res. 77:1-6.
9. Henderson DJ, Copp AJ. 1998. Versican expression is associated with chamber specification, septation, and valvulogenesis in the developing mouse heart. Circ Res. 83:523-532.
10. Hinton RB, Jr, Lincoln J, Deutsch GH, Osinska H, Manning PB, Benson DW, Yutzey KE. 2006. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res. 98:1431-1438.
11. Hoffman JI, Kaplan S. 2002. The incidence of congenital heart disease. J Am Coll Cardiol. 39:1890-1900.
12. Hoffman JI, Kaplan S, Liberthson RR. 2004. Prevalence of congenital heart disease. Am Heart J. 147:425-439.
13. Isogai Z, Aspberg A, Keene DR, Ono RN, Reinhardt DP, Sakai LY. 2002. Versican interacts with fibrillin-1 and links extracellular microfibrils to other connective tissue networks. J Biol Chem. 277:4565-4572.
14. Ito K, Shinomura T, Zako M, Ujita M, Kimata K. 1995. Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing. J Biol Chem. 270:958-965.
15. Kern CB, Norris RA, Thompson RP, Argraves WS, Fairey SE, Reyes L, Hoffman S, Markwald RR, Mjaatvedt CH. 2007. Versican proteolysis mediates myocardial regression during outflow tract development. Dev Dyn. 236:671-683.
16. Lincoln J, Alfieri CM, Yutzey KE. 2004. Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos. Dev Dyn. 230:239-250.
17. Markwald RR, Fitzharris TP, Bank H, Bernanke DH. 1978. Structural analyses on the matrical organization of glycosaminoglycans in developing endocardial cushions. Dev Biol. 62:292-316.
18. Matsumoto K, Kamiya N, Suwan K, Atsumi F, Shimizu K, Shinomura T, Yamada Y, Kimata K, Watanabe H. 2006. Identification and characterization of versican/PG-M aggregates in cartilage. J Biol Chem. 281:18257-18263.
19. Matsumoto K, Shionyu M, Go M, Shimizu K, Shinomura T, Kimata K, Watanabe H. 2003. Distinct interaction of versican/PG-M with hyaluronan and link protein. J Biol Chem. 278:41205-41212.
20. Mjaatvedt CH, Yamamura H, Capehart AA, Turner D, Markwald RR. 1998. The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev Biol. 202:56-66.
21. Nakajima Y, Yamagishi T, Hokari S, Nakamura H. 2000. Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: Roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP). Anat Rec. 258:119-127.
22. Nakamura A, Manasek FJ. 1981. An experimental study of the relation of cardiac jelly to the shape of the early chick embryonic heart. J Embryol Exp Morphol. 65:235-256.
23. Naso MF, Zimmermann DR, Iozzo RV. 1994. Characterization of the complete genomic structure of the human versican gene and functional analysis of its promoter. J Biol Chem. 269:32999-33008.
24. Olin AI, Morgelin M, Sasaki T, Timpl R, Heinegard D, Aspberg A. 2001. The proteoglycans aggrecan and Versican form networks with fibulin-2 through their lectin domain binding. J Biol Chem. 276:1253-1261.
25. Shinomura T, Nishida Y, Ito K. 1993. cDNA cloning of PG-M, a large chondroitin sulfate proteoglycan expressed during chondrogenesis in chick limb buds. Alternative spliced multiforms of PG-M and their relationships to versican. J Biol Chem. 268:14461-14469.
26. Suwan K, Choocheep K, Hatano S, Kongtawelert P, Kimata K, Watanabe H. 2009. Versican/PG-M assembles hyaluronan into extracellular matrix and inhibits CD44-mediated signaling toward premature senescence in embryonic fibroblasts. J Biol Chem. 284:8596-8604.
27. Thompson RP, Fitzharris TP. 1979a. Morphogenesis of the truncus arteriosus of the chick embryo heart: The formation and migration of mesenchymal tissue. Am J Anat. 154:545-556.
28. Thompson RP, Fitzharris TP. 1979b. Morphogenesis of the truncus arteriosus of the chick embryo heart: Tissue reorganization during septation. Am J Anat. 156:251-264.
29. Toole BP, Yu Q, Underhill CB. 2001. Hyaluronan and hyaluronan-binding proteins. Probes for specific detection. Methods Mol Biol. 171:479-485.
30. Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT, Mulligan RC. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the C-abl proto-oncogene. Cell. 65:1153-1163.
31. Ujita M, Shinomura T, Ito K, Kitagawa Y, Kimata K. 1994. Expression and binding activity of the carboxyl-terminal portion of the core protein of PG-M, a large chondroitin sulfate proteoglycan. J Biol Chem. 269:27603-27609.
32. Wirrig EE, Snarr BS, Chintalapudi MR, O'Neal JL, Phelps AL, Barth JL, Fresco VM, Kern CB, Mjaatvedt CH, Toole BP. 2007. Cartilage link protein 1 (Crtl1), an extracellular matrix component playing an important role in heart development. Dev Biol. 310:291-303.
33. Wu Y, Chen L, Cao L, Sheng W, Yang BB. 2004. Overexpression of the C-terminal PG-M/versican domain impairs growth of tumor cells by intervening in the interaction between epidermal growth factor receptor and beta1-integrin. J Cell Sci. 117:2227-2237.
34. Wu YJ, La Pierre DP, Wu J, Yee AJ, Yang BB. 2005. The interaction of versican with its binding partners. Cell Res. 15:483-494.
35. Yamagata M, Kimata K. 1994. Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG-M/versican. J Cell Sci. 107(Pt 9):2581-2590.
36. Yamagata M, Saga S, Kato M, Bernfield M, Kimata K. 1993. Selective distributions of proteoglycans and their ligands in pericellular matrix of cultured fibroblasts. Implications for their roles in cell-substratum adhesion. J Cell Sci. 106(Pt 1):55-65.
37. Zako M, Shinomura T, Ito K, Ujita M, Kimata K. 1995. Expression of PG-M (V3), an alternatively spliced form of PG-M without a chondroitin sulfate attachment in region in mouse and human tissues. J Biol Chem. 270:3914-3918.
38. Zhang Y, Cao L, Yang BL, Yang BB. 1998. The G3 domain of versican enhances cell proliferation via epidermial growth factor-like motifs. J Biol Chem. 273:21342-21351.
39. Zimmermann DR, Ruoslahti E. 1989. Multiple domains of the large fibroblast proteoglycan, versican. Embo J. 8:2975-2981.